Company intelligence / Profile preview

ProvideGx

Charlotte, North Carolina, USA

Ownership: Private
Development stage: Other

Overview

ProvideGx is a subsidiary of Premier Inc. that focuses on ensuring a continuous supply of essential generic medications that are frequently in shortage. The company partners with quality-vetted manufacturers to provide long-term, stable supply of critical drugs to health systems and hospitals. By leveraging the collective purchasing power of Premier's member hospitals, ProvideGx incentivizes manufacturers to enter or remain in the market for low-margin, high-need generic products. Its portfolio includes a wide range of products, including sterile injectables, emergency medications, and treatments for chronic conditions.

Therapeutic areas: OncologyOtherInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Non-Academic Healthcare

Partnerships

BaxterFresenius KabiHospiraViatrisAmphastar PharmaceuticalsHikma Pharmaceuticals

Beyond the preview

Go deeper on ProvideGx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProvideGx.

Explore the full profile